European markets as omicron concerns weigh on sentiment


LONDON — European stocks were mixed on Tuesday, with sentiment remaining choppy amid the continuing spread of the omicron Covid variant.

The Federal Reserve’s two-day policy meeting begins Tuesday where the policymakers are expected to discuss speeding up the end of its bond-buying program.

The meeting comes as inflation data, released last Friday, came in at 6.8% in November year over year for the biggest surge since 1982. The print was marginally higher than the 6.7% Dow Jones estimate.

U.S. stock index futures inched higher during early premarket trading on Tuesday after the major averages started the week in the red as Covid omicron fears hit sentiment.

In Asia-Pacific markets overnight, Chinese stocks declined, tracking other losses in the region, as the omicron variant returned to focus. Meanwhile, bitcoin prices continued to tumble after some losses overnight.

U.K. employment data remained strong in November, with 257,000 staff added to payrolls, indicating that the end of the government’s furlough scheme has gone smoothly.

“Without the recent emergence of the Omicron variant, today’s U.K. labour market report would likely have been enough to convince the Bank of England to hike interest rates at Thursday’s meeting,” said Hugh Gimber, global market strategist at JPMorgan Asset Management.

“Sadly, Covid-19 is yet again confusing matters. With Omicron posing near-term risks to the growth outlook, and still much to learn about the real-world efficacy of vaccines, we expect policymakers to instead opt to keep rates on hold this week in the hope that the outlook has become clearer by February.”

Deals in focus

In terms of individual share price movement, Vifor Pharma shares surged more than 12% after Australian biopharmaceutical giant CSL offered to by the Swiss company for $11.7 billion.

British online supermarket Ocado climbed 9% after a strong earnings report and a victory in a patent infringement law suit against Norwegian robotics company Autostore.

At the bottom of the European blue chip index, Rentokil shares fell more than 8% after the British pest control company agreed a $6.7 billion deal to buy U.S. rival Terminix.

Britain’s BT Group slid 5.4% after Altice U.K., the telecoms investment company controlled by French billionaire Patrick Drahi, increased its interest in the company’s voting share capital from 12.1% to 18%.

Enjoyed this article?
For exclusive stock picks, investment ideas and CNBC global livestream
Sign up for CNBC Pro
Start your free trial now

— CNBC’s Pippa Stevens and Weizhen Tan contributed to this report.

Source link

Leave A Reply

Your email address will not be published.